Jose Bazan, MD

In an interview with Pharmacy Times, Jose Bazan, MD, who leads the Breast Radiation Oncology program at City of Hope, discusses an ongoing phase 2 trial evaluating whether stereotactic body radiation therapy (SBRT) can help patients with oligoprogressive estrogen receptor (ER)-positive metastatic breast cancer remain on their current systemic therapy longer.

New findings on nodal radiation for breast cancer patients highlight the importance of lymph node involvement and tumor size in treatment decisions.

Explore the latest insights on breast cancer treatment, focusing on radiation, endocrine therapy, and the role of pharmacists in patient care.